Loki Home

Research Interests

Funding Opportunities


UI Login Guest Login

Browse by Investigator Last Name

Browse Research

Photo of David  Bushnell, Jr.

David L. Bushnell, Jr.

Professor,  Radiology

Contact Information

3811 JPP
Iowa City, IA 52242

Email: david-bushnell@uiowa.edu


MD, Medicine, University of Illinois Abraham Lincoln School of Medicine, Chicago, IL
Residency, Internal Medicine, Lutheran General Hospital, University of Illinois, affiliate Park Ridge, IL
Residency, Nuclear Medicine, University of Wisconsin Hospital & Clinics, Madison, WI


Primary: Radiology

Centers and Program Affiliations

Research Interests

MeSH Terms from Publications

Research Summary

  1. Targeted Radioisotope therapy using radiolabeled SSTR peptides
  2. Dosimetric approaches to treatment of thyroid cancer with I-131
  3. Radioimmunotherapy in patients with NHL
  4. Targeted Radioisotope therapy using I-131 MIBG

Recent Publications

Show publications
  1. Bushnell, D, Baum, R. Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am 40(1):153-62, ix, 2011. [PubMed]
  2. Boudreaux, J, Klimstra, D, Hassan, M, Woltering, E, Jensen, R, Goldsmith, S, Nutting, C, Bushnell, D, Caplin, M, Yao, J. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas 39(6):753-66, 2010. [PubMed]
  3. Kulke, M, Anthony, L, Bushnell, D, de Herder, W, Goldsmith, S, Klimstra, D, Marx, S, Pasieka, J, Pommier, R, Yao, J, Jensen, R. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39(6):735-52, 2010. [PubMed]
  4. Bushnell, D, O'Dorisio, T, O'Dorisio, M, Menda, Y, Hicks, R, Van Cutsem, E, Baulieu, J, Borson-Chazot, F, Anthony, L, Benson, A, Oberg, K, Grossman, A, Connolly, M, Bouterfa, H, Li, Y, Kacena, K, LaFrance, N, Pauwels, S. 90Y-edotreotide for metastatic carcinoid refractory to octreotide. J Clin Oncol 28(10):1652-9, 2010. [PubMed]
  5. Besse, I, Madsen, M, Bushnell, D, Juweid, M. Modeling combined radiopharmaceutical therapy: a linear optimization framework. Technol Cancer Res Treat 8(1):51-60, 2009. [PubMed]
  6. Sartor, O, Reid, R, Bushnell, D, Quick, D, Ell, P. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain. Cancer 109(3):637-43, 2007. [PubMed]
  7. Madsen, M, Bushnell, D, Juweid, M, Menda, Y, O'Dorisio, M, O'Dorisio, T, Besse, I. Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model. J Nucl Med 47(4):660-7, 2006. [PubMed]
  8. Squires, S, Bushnell, D, Menda, Y, Graham, M. Comparison of cardiac to hepatic uptake of 99mTc-tetrofosmin with and without adenosine infusion to predict the presence of haemodynamically significant coronary artery disease. Nucl Med Commun 26(6):513-8, 2005. [PubMed]
  9. Bushnell, D, Menda, Y, Madsen, M, Link, B, Kahn, D, Truhlar, S, Juweid, M, Shannon, M, Murguia, J. 99mTc-depreotide tumour uptake in patients with non-Hodgkin's lymphoma. Nucl Med Commun 25(8):839-43, 2004. [PubMed]
  10. Menda, Y, O'Dorisio, T, Floresca, J, Bushnell, DL, Juweid, M, Graham, MM. Detection of primary and recurrent carcinoid tumors with F-18FDG PET: Comparison with In-111 pentetreotide.. JOURNAL OF NUCLEAR MEDICINE 44(5):72P-73P, MAY 2003.